Xingyu Co.,Ltd(601799)
Search documents
A股公告精选 | 贵州茅台(600519.SH)2025年中期分红300亿元
智通财经网· 2025-12-10 12:04
Group 1 - Guizhou Moutai announced a mid-term profit distribution plan for 2025, with a total cash dividend of 300.01 billion yuan, distributing 23.957 yuan per share [1] - CATL plans to register and issue bonds not exceeding 10 billion yuan, with a maturity of up to 5 years, primarily for project construction and working capital [2] - Yonghui Supermarket disclosed a risk warning regarding its stock, indicating potential overheating market sentiment and high speculation risks due to significant price increases [3] Group 2 - Yuntianhua intends to acquire 100% equity of Tianyao Chemical for 36.8858 million yuan, enhancing its fine phosphorus chemical product synergy and market competitiveness [4] - Muxi Co. reported that online investors abandoned the subscription of 20,349 shares, with a total value of approximately 212.97 million yuan [5] - Ningbo Huaxiang plans to acquire 40% equity of Fengmei Power, promoting its transformation in the new energy battery and intelligent chassis sectors [6] Group 3 - Wuhan Tianyuan's subsidiary plans to invest approximately 600 million yuan in two energy storage projects [7] - Wanshun New Materials' subsidiary intends to acquire 100% equity of Eurofoil Luxembourg for 12.3889 million euros, enhancing its market presence in the aluminum foil and sheet industry [9] - Medike plans to introduce strategic investors for its subsidiary, raising 200 million yuan for business expansion [10] Group 4 - Century Huatong's subsidiary holds 7.3121% of Guosheng Capital, which owns 1,958,887 shares of Moer Thread, potentially impacting the company's net profit significantly [11] - Dingyang Technology launched the SPB3000X series of simulators, aiming for large-scale sales while facing market promotion challenges [12] - Baiyun Airport reported a passenger throughput of 7.3228 million in November, a year-on-year increase of 12.58% [13] Group 5 - ST Yigou's subsidiary sold eight subsidiaries, expecting to increase net profit by approximately 992 million yuan [14] - Shennong Development reported a sales revenue of 1.81 billion yuan in November, a year-on-year increase of 15.77% [15][16] - Minhe's sales revenue from broiler chicks increased by 7.75% month-on-month, despite a year-on-year decline [17] Group 6 - Xiaoming's sales revenue from chicken products decreased by 49.73% year-on-year, influenced by market supply and demand dynamics [18] - Hefei China reported a consolidated revenue of 628 million yuan from January to November, a year-on-year decline of 26.02% [19] - Xiantan's chicken product sales revenue increased by 11.63% year-on-year, supported by ongoing project developments [20] Group 7 - Tian Nai Technology's major shareholders plan to reduce their holdings by up to 2.5% [21] - Xingyu Co. intends to repurchase shares worth 200 to 300 million yuan for employee stock ownership plans [22] - Baiao Chemical adjusted its share repurchase price ceiling to not exceed 48.95 yuan per share [23] Group 8 - Jicheng Electronics won contracts totaling approximately 215 million yuan from the State Grid [25] - Ruikemi received a development notice from a well-known flying car company for core component supply [26]
12月10日晚间重要公告一览
Xi Niu Cai Jing· 2025-12-10 10:11
Group 1 - Jicheng Electronics won a total of 15 bids from the State Grid Corporation, with a total bid amount of approximately 215 million yuan, accounting for 8.27% of the company's projected revenue for 2024 [2] - Jianmin Group's chemical generic drug, Ambrutoro Oral Solution, has been approved for market launch by the National Medical Products Administration, aimed at treating cough and wheezing caused by chronic bronchitis and emphysema [3] - Taiji Industry's subsidiary plans to transfer accounts receivable not exceeding 85 million USD to optimize cash flow, with an expected service fee of approximately 285,000 USD [4] Group 2 - Nanjing Pharmaceutical's subsidiary plans to invest 398 million yuan in a modern pharmaceutical logistics expansion project, with a construction period of approximately 35 months [5] - Ruili Kemi received a development notification from a well-known domestic flying car company to supply core components [6] - Ding Tong Technology announced that several executives plan to reduce their holdings by a total of no more than 45,300 shares, representing about 0.032% of the total share capital [7][8] Group 3 - Ninghu Expressway's subsidiary plans to invest no more than 9.033 billion yuan in the construction of the Nanyang Yangtze River Bridge South Connection Project [10] - Wuliangye announced a mid-term profit distribution plan for 2025, proposing a cash dividend of 25.78 yuan per 10 shares, totaling approximately 10 billion yuan [12] - Beixin Road and Bridge's subsidiary won a bid for a project worth 180 million yuan [14] Group 4 - Minhe Livestock reported a 7.75% month-on-month increase in sales revenue from commodity chick sales in November [15] - Xuelong Group plans to invest 100 million yuan to establish a wholly-owned subsidiary for vertical integration in the aluminum and magnesium technology sector [16] - Shengnong Development reported a 15.77% year-on-year increase in sales revenue in November, with significant growth in both poultry and processed meat products [17] Group 5 - Xingyu Co., Ltd. plans to repurchase shares worth 200 million to 300 million yuan for employee stock ownership plans [18] - Quan Chai Power intends to use 50 million yuan of idle funds to purchase structured deposit products [19] - Shibei High-tech appointed Zhao Junhong as the new deputy general manager [20] Group 6 - Fuan Pharmaceutical's subsidiary received a drug registration certificate for injectable isavuconazole, expanding its anti-infection product line [21] - Xiaoming Co. reported a 49.73% year-on-year decline in chicken product sales revenue in November [22] - Baiao Chemical adjusted its share repurchase price ceiling to no more than 48.95 yuan per share [23] Group 7 - Hefei China reported a 26.02% year-on-year decline in consolidated revenue for the first 11 months [24] - Laimei Pharmaceutical's subsidiary received medical device registration certificates for two endoscope products [25][26] - Xiantan Co. reported an 11.63% year-on-year increase in chicken product sales revenue in November [27] Group 8 - Qilin Security received government subsidies totaling 5.4014 million yuan [28] - Blue Sky Gas's controlling shareholder's 30.9134 million shares were judicially frozen, accounting for 4.33% of the total share capital [29] - Tieke Railway signed a contract for high-speed railway fasteners worth 654 million yuan, accounting for 41.08% of the company's projected revenue for 2024 [30] Group 9 - David Medical's electric surgical table received a medical device registration certificate [31] - Zhendong Pharmaceutical's affiliate's core product new drug application was accepted by the CDE [32] - Shanghai Pharmaceutical's apple acid sitagliptin tablet application for market approval was granted by the National Medical Products Administration [33] Group 10 - Nanjiao Food reported a 1.14% year-on-year increase in consolidated revenue for November [34]
星宇股份(601799) - 星宇股份关于以集中竞价交易方式回购股份方案的公告
2025-12-10 08:48
证券简称:星宇股份 证券代码:601799 编号:2025-038 常州星宇车灯股份有限公司 重要内容提示: 1、相关股东是否存在减持计划:截至本公告披露日,公司董事、高级管理 人员、公司控股股东、实际控制人及一致行动人、持股 5%以上的股东在未来 3 个月、未来 6 个月内无减持公司股份的计划。若上述主体未来有减持计划,公司 将按照法律法规及规范性文件要求及时履行信息披露义务。 2、若本次回购期限内公司股票价格持续超出回购价格上限,将导致本次回 购方案无法顺利实施或者只能部分实施的风险。 3、若发生对公司股票交易价格产生重大影响的重大事项,或公司生产经营 财务情况、外部客观情况发生重大变化,或其他导致公司董事会决定终止本次回 购方案的事项发生,则存在回购方案无法顺利实施或者根据相关规定变更或终止 本次回购方案的风险。 4、本次回购股份拟用于员工持股计划,可能面临因相关方案未能经公司董 事会或股东会等决策机构审议通过或其他原因导致已回购股份无法全部转让的 风险。若出现上述情形,公司将依法履行相关股份注销程序。 5、如遇监管部门颁布新的回购相关规范性文件,导致本次回购实施过程中 需要根据监管新规调整回购相应条款 ...
星宇股份(601799) - 星宇股份关于使用暂时闲置的公开发行A股可转换公司债券募集资金进行现金管理的公告
2025-12-10 08:45
关于使用暂时闲置的公开发行 A 股可转换公司债券 募集资金进行现金管理的公告 证券简称:星宇股份 证券代码:601799 编号:2025-039 常州星宇车灯股份有限公司 截至 2025 年 11 月 30 日,公司公开发行 A 股可转换公司债券募集资金已使 用 128,452.16 万元,募集资金余额 30,344.35 万元(含利息收入及待支付合同 款)。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏,并对其内容的真实性、准确性和完整性承担法律责任。 根据中国证监会《上市公司募集资金监管规则》、《上海证券交易所上市公司 自律监管指引第 1 号——规范运作》以及公司募集资金管理制度等相关规定,常 州星宇车灯股份有限公司(以下简称"公司")于 2025 年 12 月 10 日召开第七届 董事会第五次会议,审议通过《关于使用暂时闲置的公开发行 A 股可转换公司 债券募集资金进行现金管理的议案》,同意公司使用公开发行 A 股可转换公司债 券募集资金适时购买安全性高、流动性好、低风险的保本型理财产品,最高额度 不超过 2.00 亿元。现将相关事项公告如下: 一、本次募集资金的基本 ...
星宇股份(601799) - 国泰海通关于星宇股份使用暂时闲置募集资金进行现金管理的核查意见
2025-12-10 08:45
国泰海通证券股份有限公司 关于常州星宇车灯股份有限公司 使用暂时闲置募集资金进行现金管理的核查意见 国泰海通证券股份有限公司(以下简称"国泰海通证券")作为常州星宇车 灯股份有限公司(以下简称"星宇股份"或"公司")2020 年度公开发行可转换 公司债券(以下简称"本次发行")的保荐机构,根据《上市公司募集资金监管 规则》《上海证券交易所股票上市规则》《上海证券交易所上市公司自律监管指引 第 1 号——规范运作》等相关法律法规和规范性文件的规定,对星宇股份使用暂 时闲置募集资金进行现金管理进行了审慎核查,并发表意见如下: 一、本次公开发行可转换公司债券募集资金到位情况 经中国证券监督管理委员会《关于核准常州星宇车灯股份有限公司公开发行 可转换公司债券的批复》(证监许可[2020]2262 号),星宇股份向社会公开发行面 值总额 15 亿元的可转换公司债券,期限 6 年,募集资金总额 1,500,000,000.00 元, 扣除相关中介费用及其他发行费用(不含增值税)共计 9,395,283.00 元后,募集 资金净额 1,490,604,717.00 元。天衡会计师事务所(特殊普通合伙)己对本次发 行的募集资 ...
星宇股份(601799) - 星宇股份第七届董事会第五次会议决议公告
2025-12-10 08:45
一、董事会会议召开情况 (一)本次会议的召开符合有关法律、行政法规、部门规章、规范性文件和公 司章程的规定。 (二)本次会议通知于 2025 年 12 月 5 日以电话、电子邮件和现场送达的方式 发出。 (三)本次会议于 2025 年 12 月 10 日在本公司以现场结合通讯表决方式召开。 证券简称:星宇股份 证券代码:601799 编号:2025-037 常州星宇车灯股份有限公司 第七届董事会第五次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏,并对其内容的真实性、准确性和完整性承担法律责任。 (四)本次会议应出席董事七人,实际出席董事七人。 (五)本次会议由公司董事长周晓萍女士主持,公司部分高级管理人员及董事 会秘书列席了本次会议。 二、董事会会议审议情况 经审议,会议做出如下决议: (一)审议通过《关于以集中竞价交易方式回购股份的议案》 表决结果:7 票同意,0 票反对,0 票弃权 为促进公司健康稳定发展,建立长效激励机制,基于对公司未来发展前景的 信心以及对公司价值的高度认可,在综合考虑公司财务状况以及未来盈利能力的 情况下,公司依据中国证监会和上海证券 ...
星宇股份(601799.SH):拟斥资2亿元-3亿元回购股份
Ge Long Hui· 2025-12-10 08:40
财经频道更多独家策划、专家专栏,免费查阅>> 责任编辑:安东 格隆汇12月10日丨星宇股份(601799.SH)公布,公司回购股份拟用于员工持股计划,拟回购金额不低于 20,000万元且不高于30,000万元,回购价格不高于180元/股。 ...
星宇股份拟2亿元至3亿元回购公司股份
Zhi Tong Cai Jing· 2025-12-10 08:39
星宇股份(601799)(601799.SH)发布公告,公司拟以自有资金通过集中竞价交易方式回购部分公司股 份,并拟将所回购股份用于员工持股计划。拟回购金额不低于2亿元且不高于3亿元,回购价格不高于 180元/股。 ...
星宇股份(601799.SH)拟2亿元至3亿元回购公司股份
智通财经网· 2025-12-10 08:38
智通财经APP讯,星宇股份(601799.SH)发布公告,公司拟以自有资金通过集中竞价交易方式回购部分 公司股份,并拟将所回购股份用于员工持股计划。拟回购金额不低于2亿元且不高于3亿元,回购价格不 高于180元/股。 ...
星宇股份:拟2亿元至3亿元回购股份
Zheng Quan Shi Bao Wang· 2025-12-10 08:34
人民财讯12月10日电,星宇股份(601799)12月10日公告,公司拟2亿元至3亿元回购股份用于员工持股 计划,回购价格不高于180元/股。 ...